Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data.

<h4>Background</h4>People with neuromuscular disease (NMD) experience a broader range of chronic diseases and health symptoms compared to the general population. However, no comprehensive analysis has directly quantified this to our knowledge.<h4>Methods</h4>We used a large U...

Full description

Bibliographic Details
Main Authors: Iain M Carey, Niranjanan Nirmalananthan, Tess Harris, Stephen DeWilde, Umar A R Chaudhry, Elizabeth Limb, Derek G Cook
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0282513
_version_ 1797842843355578368
author Iain M Carey
Niranjanan Nirmalananthan
Tess Harris
Stephen DeWilde
Umar A R Chaudhry
Elizabeth Limb
Derek G Cook
author_facet Iain M Carey
Niranjanan Nirmalananthan
Tess Harris
Stephen DeWilde
Umar A R Chaudhry
Elizabeth Limb
Derek G Cook
author_sort Iain M Carey
collection DOAJ
description <h4>Background</h4>People with neuromuscular disease (NMD) experience a broader range of chronic diseases and health symptoms compared to the general population. However, no comprehensive analysis has directly quantified this to our knowledge.<h4>Methods</h4>We used a large UK primary care database (Clinical Practice Research Datalink) to compare the prevalence of chronic diseases and other health conditions, including recent infections between 23,876 patients with NMD ever recorded by 2019 compared to 95,295 age-sex-practice matched patients without NMD. Modified Poisson regression estimated Prevalence Ratios (PR) to summarise the presence of the disease/condition ever (or for infections in 2018) in NMD patients versus non-NMD patients.<h4>Results</h4>Patients with NMD had significantly higher rates for 16 of the 18 conditions routinely recorded in the primary care Quality and Outcomes Framework (QOF). Approximately 1-in-10 adults with NMD had ≥4 conditions recorded (PR = 1.39, 95%CI 1.33-1.45). Disparities were more pronounced at younger ages (18-49). For other (non-QOF) health conditions, significantly higher recorded levels were observed for rarer events (pulmonary embolism PR = 1.96 95%CI 1.76-2.18, hip fractures PR = 1.65 95%CI 1.47-1.85) as well as for more common primary care conditions (constipation PR = 1.52 95%CI 1.46-1.57, incontinence PR = 1.52 95%CI 1.44-1.60). The greatest co-morbidity burden was in patients with a myotonic disorder. Approximately 1-in-6 (17.1%) NMD patients had an infection recorded in the preceding year, with the risk of being hospitalised with an infection nearly double (PR = 1.92, 95%CI 1.79-2.07) compared to non-NMD patients.<h4>Conclusion</h4>The burden of chronic co-morbidity among patients with NMD is extremely high compared to the general population, and they are also more likely to present in primary and secondary care for acute events such as infections.
first_indexed 2024-04-09T16:54:49Z
format Article
id doaj.art-7328ff275cd74863ae421333aa3a4137
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-09T16:54:49Z
publishDate 2023-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-7328ff275cd74863ae421333aa3a41372023-04-21T05:36:24ZengPublic Library of Science (PLoS)PLoS ONE1932-62032023-01-01183e028251310.1371/journal.pone.0282513Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data.Iain M CareyNiranjanan NirmalananthanTess HarrisStephen DeWildeUmar A R ChaudhryElizabeth LimbDerek G Cook<h4>Background</h4>People with neuromuscular disease (NMD) experience a broader range of chronic diseases and health symptoms compared to the general population. However, no comprehensive analysis has directly quantified this to our knowledge.<h4>Methods</h4>We used a large UK primary care database (Clinical Practice Research Datalink) to compare the prevalence of chronic diseases and other health conditions, including recent infections between 23,876 patients with NMD ever recorded by 2019 compared to 95,295 age-sex-practice matched patients without NMD. Modified Poisson regression estimated Prevalence Ratios (PR) to summarise the presence of the disease/condition ever (or for infections in 2018) in NMD patients versus non-NMD patients.<h4>Results</h4>Patients with NMD had significantly higher rates for 16 of the 18 conditions routinely recorded in the primary care Quality and Outcomes Framework (QOF). Approximately 1-in-10 adults with NMD had ≥4 conditions recorded (PR = 1.39, 95%CI 1.33-1.45). Disparities were more pronounced at younger ages (18-49). For other (non-QOF) health conditions, significantly higher recorded levels were observed for rarer events (pulmonary embolism PR = 1.96 95%CI 1.76-2.18, hip fractures PR = 1.65 95%CI 1.47-1.85) as well as for more common primary care conditions (constipation PR = 1.52 95%CI 1.46-1.57, incontinence PR = 1.52 95%CI 1.44-1.60). The greatest co-morbidity burden was in patients with a myotonic disorder. Approximately 1-in-6 (17.1%) NMD patients had an infection recorded in the preceding year, with the risk of being hospitalised with an infection nearly double (PR = 1.92, 95%CI 1.79-2.07) compared to non-NMD patients.<h4>Conclusion</h4>The burden of chronic co-morbidity among patients with NMD is extremely high compared to the general population, and they are also more likely to present in primary and secondary care for acute events such as infections.https://doi.org/10.1371/journal.pone.0282513
spellingShingle Iain M Carey
Niranjanan Nirmalananthan
Tess Harris
Stephen DeWilde
Umar A R Chaudhry
Elizabeth Limb
Derek G Cook
Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data.
PLoS ONE
title Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data.
title_full Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data.
title_fullStr Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data.
title_full_unstemmed Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data.
title_short Prevalence of co-morbidity and history of recent infection in patients with neuromuscular disease: A cross-sectional analysis of United Kingdom primary care data.
title_sort prevalence of co morbidity and history of recent infection in patients with neuromuscular disease a cross sectional analysis of united kingdom primary care data
url https://doi.org/10.1371/journal.pone.0282513
work_keys_str_mv AT iainmcarey prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT niranjanannirmalananthan prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT tessharris prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT stephendewilde prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT umararchaudhry prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT elizabethlimb prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata
AT derekgcook prevalenceofcomorbidityandhistoryofrecentinfectioninpatientswithneuromusculardiseaseacrosssectionalanalysisofunitedkingdomprimarycaredata